BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 6826564)

  • 1. Domain structure of the carboxyl-terminal half of human plasma fibronectin.
    Hayashi M; Yamada KM
    J Biol Chem; 1983 Mar; 258(5):3332-40. PubMed ID: 6826564
    [No Abstract]   [Full Text] [Related]  

  • 2. Domain structure of human plasma and cellular fibronectin. Use of a monoclonal antibody and heparin affinity to identify three different subunit chains.
    Click EM; Balian G
    Biochemistry; 1985 Nov; 24(23):6685-96. PubMed ID: 2417623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary structure of a DNA- and heparin-binding domain (Domain III) in human plasma fibronectin.
    Calaycay J; Pande H; Lee T; Borsi L; Siri A; Shively JE; Zardi L
    J Biol Chem; 1985 Oct; 260(22):12136-41. PubMed ID: 3900070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in domain structures between plasma and cellular fibronectins.
    Hayashi M; Yamada KM
    J Biol Chem; 1981 Nov; 256(21):11292-300. PubMed ID: 7287767
    [No Abstract]   [Full Text] [Related]  

  • 5. Primary structure of human plasma fibronectin. The 29,000-dalton NH2-terminal domain.
    Garcia-Pardo A; Pearlstein E; Frangione B
    J Biol Chem; 1983 Oct; 258(20):12670-4. PubMed ID: 6630202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Domain structure of human plasma fibronectin. Differences and similarities between human and hamster fibronectins.
    Sekiguchi K; Hakomori S
    J Biol Chem; 1983 Mar; 258(6):3967-73. PubMed ID: 6833239
    [No Abstract]   [Full Text] [Related]  

  • 7. Inaccessibility to ligands of the amino-terminal region of plasma fibronectin.
    Homandberg GA
    Thromb Res; 1987 Nov; 48(3):321-7. PubMed ID: 3433256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human placental (fetal) fibronectin: increased glycosylation and higher protease resistance than plasma fibronectin. Presence of polylactosamine glycopeptides and properties of a 44-kilodalton chymotryptic collagen-binding domain: difference from human plasma fibronectin.
    Zhu BC; Fisher SF; Pande H; Calaycay J; Shively JE; Laine RA
    J Biol Chem; 1984 Mar; 259(6):3962-70. PubMed ID: 6423638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a plasma gelatinase in preparations of fibronectin.
    Johansson S; Smedsrød B
    J Biol Chem; 1986 Apr; 261(10):4363-6. PubMed ID: 3007451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NH2-terminal sequences of DNA-, heparin-, and gelatin-binding tryptic fragments from human plasma fibronectin.
    Pande H; Shively JE
    Arch Biochem Biophys; 1982 Jan; 213(1):258-65. PubMed ID: 7059179
    [No Abstract]   [Full Text] [Related]  

  • 11. Two plasma fibronectin fragments with different gelatin-binding properties.
    Griffin CA; Calaycay J; Shively JE; Smith RL
    Thromb Res; 1986 Aug; 43(4):469-77. PubMed ID: 3532418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interdomain cleavage of plasma fibronectin by zinc-metalloproteinase from Serratia marcescens.
    Molla A; Tanase S; Hong YM; Maeda H
    Biochim Biophys Acta; 1988 Jun; 955(1):77-85. PubMed ID: 3289620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the binding domains in the fragments cleaved by cathepsin G from human plasma fibronectin.
    Vartio T
    Eur J Biochem; 1982 Apr; 123(2):223-33. PubMed ID: 7075587
    [No Abstract]   [Full Text] [Related]  

  • 14. Primary structure of human plasma fibronectin. Characterization of a 38 kDa domain containing the C-terminal heparin-binding site (Hep III site) and a region of molecular heterogeneity.
    Garcia-Pardo A; Rostagno A; Frangione B
    Biochem J; 1987 Feb; 241(3):923-8. PubMed ID: 3593230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Divalent cation modulation of fibronectin binding to heparin and to DNA.
    Hayashi M; Yamada KM
    J Biol Chem; 1982 May; 257(9):5263-7. PubMed ID: 6802851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The biochemical and functional heterogeneity of circulating human plasma fibronectin.
    Boughton BJ; Simpson AW
    Biochem Biophys Res Commun; 1984 Mar; 119(3):1174-80. PubMed ID: 6712671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Demonstration of structural differences between the two subunits of human-plasma fibronectin in the carboxy-terminal heparin-binding domain.
    Pande H; Calaycay J; Lee TD; Legesse K; Shively JE; Siri A; Borsi L; Zardi L
    Eur J Biochem; 1987 Jan; 162(2):403-11. PubMed ID: 3803394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of fibronectin fragments that bind to carboxy-group-modified proteins.
    Vuento M; Sekiguchi K; Korkolainen M
    Biochem J; 1983 Dec; 215(3):613-6. PubMed ID: 6661187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural and functional comparisons of chicken and human cellular fibronectins.
    Bernard BA; Akiyama SK; Newton SA; Yamada KM; Olden K
    J Biol Chem; 1984 Aug; 259(15):9899-905. PubMed ID: 6146622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Location of a gelatin-binding region of human plasma fibronectin.
    Furie MB; Frey AB; Rifkin DB
    J Biol Chem; 1980 May; 255(10):4391-4. PubMed ID: 7372581
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.